TIDMIIG

RNS Number : 7737L

Intuitive Investments Group plc

15 September 2021

Intuitive Investments Group plc

Investment in Momentum Bioscience Limited

Intuitive Investments Group plc (AIM: IIG) ("IIG" or the "Company"), a closed-end investment company focussed on the life sciences sector, is pleased to announce an investment of GBP125,000 to acquire 25,000 new A preferred shares in Momentum Bioscience Limited ("Momentum") (the "Investment") as part of a GBP3.89 million fundraising round ("Fundraising"). The Investment provides IIG with a 2.4 per cent. interest in Momentum's share capital as enlarged by the Fundraising.

Momentum is developing a revolutionary rapid diagnostic test for patients suspected of sepsis, an infection of the blood stream resulting in symptoms including a drop in a blood pressure, increase in heart rate and fever. Last year, the World Health Organisation ("WHO") reported that there were 49 million deaths from sepsis globally and 11 million avoidable deaths. The current standard of care typically takes 1-5 days to detect viable bacteria or fungi (organisms) in blood, relying on downstream workflows to provide an identification of the organism thereafter.

Momentum's SepsiSTAT(R) system enables reporting of the presence or absence and 'pan gram identification' of viable organisms in just two hours, helping direct the right antimicrobials. The system also provides a pure concentrate of growing organisms for further analysis.

Faster testing in suspected sepsis patients can reduce mortality, accelerate hospital discharge, lower hospital costs and reduce pressure on antimicrobial resistance. SepsiSTAT(R) is a diagnostic test that runs from a sample of whole blood before any culturing steps are taken and is currently being studied in clinical practice with highly encouraging early results indicating competitive sensitivity versus the current standard of care. Over 120 million blood tests for sepsis are run annually representing a market potential of over GBP1.0 billion.

Further information can be found on Momentum's website: www.momentumbio.co.uk.

Momentum, per the company's unaudited management accounts for the eight months to 30 June 2021, had no revenues and a loss after tax of GBP1,391,769 and, as at 30 June 2021, had net liabilities of GBP59,112.

David Evans, Executive Chairman of the Company, personally invested in Momentum in 2008 and will invest GBP125,000 to acquire 25,000 new A preferred shares in Momentum in the Fundraising. David Evans' resulting position represents a 2.5 per cent. interest in Momentum's share capital as enlarged by the Fundraising. Accordingly, David Evans did not vote as a member of the Board approving the Investment.

For further information, please contact:

 
 Intuitive Investments Group plc                                       www.iigplc.com 
 David Evans, Executive Chairman                                      Via Walbrook PR 
  Robert Naylor, CEO 
 
 Strand Hanson Limited - Nominated 
  Adviser                                                        +44 (0) 20 7409 3494 
 James Dance / James Bellman 
 Turner Pope Investments (TPI) 
  Ltd - Broker                                                   +44 (0) 20 3657 0050 
 Andrew Thacker / James Pope 
 
 Walbrook PR Limited - Media &        +44 (0)20 7933 8780 or intuitive@walbrookpr.com 
  Investor Relations 
                                                        +44 (0)7502 558 258 / +44 (0) 
 Sam Allen / Paul McManus                                                7980 541 893

About Intuitive Investments Group plc

The Company is a recently established investing company, seeking to provide investors with exposure to a portfolio concentrating on fast growing and/or high potential Life Sciences businesses operating predominantly in the UK, continental Europe and the US, utilising the Board's experience and in particular that of the Chairman, David Evans, to seek to generate capital growth over the long term for shareholders.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCUSSNRAUUKAAR

(END) Dow Jones Newswires

September 15, 2021 01:59 ET (05:59 GMT)

Intuitive Investments (LSE:IIG)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024 Haga Click aquí para más Gráficas Intuitive Investments.
Intuitive Investments (LSE:IIG)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024 Haga Click aquí para más Gráficas Intuitive Investments.